17
May
On May 13, 2019, the U.S. Trade Representative (“USTR”) issued a proposed List 4 which threatens to impose additional tariffs of up to 25% on “essentially all” Chinese products imported into the U.S. that were not covered by previous section 301 pronouncements.
Pharmaceuticals, certain chemicals made into prescription pharmaceuticals, rare earth minerals and critical minerals are excluded from this latest action. The remaining product categories cover 3,805 full and partial tariff subheadings. The list includes toys, apparel, shoes, food and...